Ebola in Congo, confirmed cases pass 5,000: WHO maintains international emergency

A story the morning edition did not report, with a new development dated August 18: the World Health Organization’s Emergency Committee has confirmed that the Ebola outbreak in the Democratic Republic of the Congo remains a public health emergency of international concern, a status declared on May 16, 2026. Director-General Tedros Adhanom Ghebreyesus reiterated the assessment: “The Ebola outbreak in the DRC remains a public health emergency of international concern,” as reported by Outbreak News Today.

The figures, updated as of Sunday, August 16, and attributed to the Congolese Ministry of Health, are 5,021 confirmed cases and 2,378 deaths. They are reported by the Associated Press, picked up by NPR and the Washington Post: the two outlets trace back to the same agency and therefore count as a single source, alongside which stands the World Health Organization as a second, independent source.

Indicator	Value
Confirmed cases (August 16)	5,021
Deaths	2,378
Provinces affected	6
Health zones involved	55
Overall case fatality rate	47.4%
Case fatality rate in North Kivu	70%

The figure that best describes the situation is not the total, but the gap between the two fatality rates. An average of 47.4% with a peak of 70% in a single province indicates that mortality does not depend solely on the virus, but on the ability to detect and treat cases: where access to facilities is more difficult, the same infection kills more. North Kivu is the province where this gap is measured.

A second indicator concerns personnel: according to the WHO, 155 health workers have been infected and 45 of them have died. In a filovirus outbreak, infection among health workers is both a human cost and a systemic problem, because it removes precisely the expertise needed to contain transmission.

On vaccines, precision is required, and here precision is restrictive. The outbreak is caused by the Bundibugyo virus, for which no approved vaccines or treatments exist: the available products are certified for the Zaire strain. Vaccine trials are underway in the United Kingdom and Canada, with the first dose administered to a volunteer last month. These are trials that have only just begun: no efficacy results have been published, the sample is the initial cohort of a clinical trial, and administration to a healthy volunteer says nothing about protection against infection. As things stand, based on the information available, there is no field-deployable prophylaxis for this strain.

This newspaper does not issue health guidance: it reports the decisions of the identified authorities. The decision taken on August 18 has concrete effects — the maintenance of the international emergency is the legal framework within which the WHO issues temporary recommendations to states and coordinates the response.

The figure to watch in upcoming updates is the number of health zones: 55 across six provinces measures the geographic extent, and its variation will show whether containment is working better than the case count, which also depends on testing capacity.